PARA LA GENTE QUE SE INTERESE EN EL TEMA

ESTA ES LA LISTA DE LOS VÍNCULOS DE PAGINAS RELEVANTES DE LOS ESTAMENTOS RELACIONADOS CON EL CONTROL Y SUPERVISION DE LA INVESTIGACIÓN CLÍNICA PATROCINADA EN DIFERENTES PAÍSES EN REFERENCIA AL TEMA DE LA PANDEMIA DE COVID-19

 

  • FDA (Estados Unidos de América)

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-pandemic

 

  • EMA (Comunidad Europea)

https://www.ema.europa.eu/en/news/guidance-sponsors-how-manage-clinical-trials-during-covid-19-pandemic

 

  • Health Canada (Canada)

https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/management-clinical-trials-during-covid-19-pandemic.html

 

  • Swiss Medic (Suiza)

https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/klv-cov-2-pandemie-2.html

 

  • NHMRC (Australia)

https://www.medicalresearch.nsw.gov.au/covid-19-clinical-trial-guidance/

https://www.nhmrc.gov.au/sites/default/files/documents/attachments/ctprg-statement-clinical-trials-covid.pdf

 

  • MHRA (Reino Unido)

https://www.hra.nhs.uk/covid-19-research/covid-19-guidance-sponsors-sites-and-researchers/

https://www.gov.uk/government/collections/mhra-guidance-on-coronavirus-covid-19

 

  • HPRA (Irlanda)

http://www.hpra.ie/homepage/medicines/regulatory-information/clinical-trials/covid-19-(coronavirus)-and-cts

 

  • BFARM (Alemania)

https://www.bfarm.de/EN/Drugs/licensing/clinicalTrials/news/CT_COVID19.html

 

  • AEMPS (España)

https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/2020-medicamentosusohumano-3/medidas-excepcionales-aplicables-a-los-ensayos-clinicos-para-gestionar-los-problemas-derivados-de-la-emergencia-por-covid-19/

 

  • ANSM (Francia)

https://www.ansm.sante.fr/Activites/Essais-cliniques/COVID-19-Ongoing-clinical-trials/(offset)/1#paragraph_172523

 

  • AIFA (Italia)

https://www.aifa.gov.it/web/guest/-/gestione-degli-studi-clinici-in-italia-in-corso-di-emergenza-covid-19-coronavirus-disease-19-07-04-2020-

 

  • PMDA (Japón)

https://www.pmda.go.jp/review-services/trials/0020.html

 

  • HSA (Singapur)

https://www.hsa.gov.sg/docs/default-source/hprg-io-ctb/hsa_ctb_covid-19_guidance_for_clinical_trials_27mar2020.pdf

 

  • ANMAT (Argentina)

https://www.argentina.gob.ar/noticias/medidas-y-recomendaciones-en-los-estudios-de-farmacologia-clinica-durante-la-pandemia-covid

 

  • ANVISA (Brasil)

http://portal.anvisa.gov.br/documents/2857848/5583613/NT+pesquisa+cl%C3%ADnica+Covid+-+19.pdf/924af08a-21e0-4025-b001-06dae6f6344b

 

  • INVIMA (Colombia)

https://www.invima.gov.co/documents/20143/1675238/medidas-excepcionales-de-investigacion-clinica_vf.pdf/e4b85c32-9515-d76d-c0f6-3c0566dbe85e?t=1584654646760

  • OGITT/INS (Perú)

 

https://ensayosclinicos-repec.ins.gob.pe/otros-repec/comunicados/309-comunicado-n-002-2020-ogitt-ins

 

  • ACRO

https://www.acrohealth.org/acro-considerations-on-monitoring-during-covid-19/

 

  • TransCelerate

https://transceleratebiopharmainc.com/covid-19/